Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Inazu

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
The American Journal of Cardiology|July 13, 1995
Clinical efficacy of fluvastatin in the long-term treatment of familial hypercholesterolemiaJ Koizumi, T Haraki, K Yagi, et al.
Biochemistry|March 3, 1992
Alternative splicing of the mRNA encoding the human cholesteryl ester transfer proteinA Inazu, E M Quinet, S Wang, et al.
Journal of Lipid Research|November 9, 2006
A novel method for measuring human hepatic lipase activity in postheparin plasmaS Imamura, J Kobayashi, S Sakasegawa, et al.
Journal of Lipid Research|March 1, 1997
Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiencyX P Yang, A Inazu, A Honjo, et al.
The Journal of Clinical Investigation|November 1, 1994
Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterolA Inazu, X C Jiang, T Haraki, et al.
Atherosclerosis|October 1, 1991
Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiencyJ Koizumi, A Inazu, K Yagi, et al.
Clinical Nephrology|August 28, 2001
Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal diseaseT Haraki, T Takegoshi, C Kitoh, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 31, 2008
Postprandial triglyceridaemia in men with impaired fasting glucose, impaired glucose tolerance and diabetesR Oka, K Yagi, S Hifumi, et al.
The New England Journal of Medicine|November 1, 1990
Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutationA Inazu, M L Brown, C B Hesler, et al.
Clinical Pharmacology and Therapeutics|October 25, 2007
Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover studyM-a Kawashiri, A Nohara, H Tada, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|July 13, 1995
Clinical efficacy of fluvastatin in the long-term treatment of familial hypercholesterolemiaJ Koizumi, T Haraki, K Yagi, et al.
Biochemistry|March 3, 1992
Alternative splicing of the mRNA encoding the human cholesteryl ester transfer proteinA Inazu, E M Quinet, S Wang, et al.
Journal of Lipid Research|November 9, 2006
A novel method for measuring human hepatic lipase activity in postheparin plasmaS Imamura, J Kobayashi, S Sakasegawa, et al.
Journal of Lipid Research|March 1, 1997
Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiencyX P Yang, A Inazu, A Honjo, et al.
The Journal of Clinical Investigation|November 1, 1994
Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterolA Inazu, X C Jiang, T Haraki, et al.
Atherosclerosis|October 1, 1991
Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiencyJ Koizumi, A Inazu, K Yagi, et al.
Clinical Nephrology|August 28, 2001
Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal diseaseT Haraki, T Takegoshi, C Kitoh, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 31, 2008
Postprandial triglyceridaemia in men with impaired fasting glucose, impaired glucose tolerance and diabetesR Oka, K Yagi, S Hifumi, et al.
The New England Journal of Medicine|November 1, 1990
Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutationA Inazu, M L Brown, C B Hesler, et al.
Clinical Pharmacology and Therapeutics|October 25, 2007
Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover studyM-a Kawashiri, A Nohara, H Tada, et al.
Pageof 6